黄视频国产-久久免费看少妇a高潮一片黄特-日韩综合亚洲色在线影院-欧美午夜刺激影院-无卡无码无免费毛片-狠狠色狠狠色很很综合很久久-久久情趣视频-日韩一级黄色录像-99在线观看精品-美女xx00-狠狠干中文字幕-永久免费未满视频-999热精品视频-日本一区二区在线免费观看-五月婷网站-天天干狠狠-无遮高潮国产免费观看-bt男人天堂-亚洲欧美日韩精品永久在线-国产成人无码久久久精品一

Many industrial innovative products are coming soon

COVID-19 antibody detection reagent and many other products go out of China and enter the international market

Expanded R&D team and introduced new R&D technology

Realized whole-line cold chain logistics for the first time nationwide

Completed the development and started the clinical test of many industry-leading project, such as irradiator, multiple, HIV, etc.

Be recognized as provincial level innovation and industrialization demonstration enterprise for several times

Established "Guangdong Postdoctoral Innovation Practice Base"

Be approved as a national “Post-Doctoral Research Center”

Established Suzhou R&D center

Moved into the new industrial park with a floor area of 23,000 m2

Cooperated with many international IVD enterprises, such as Unipath, Fujirebro, Siemens, MP, etc.

The market share of AIDS confirmation reagents reached 80%, and the market share of drug concentration detection reached 50%,Many self-developed products occupied over 60% of the market share.Many products became reference methods for disease detection, such as MYCOII and TP.PA.

1989, the first subsidiary of Livzon Pharmaceutical Group Inc.

Obtained pharmaceutical manufacturing license

Many products were successfully developed and marketed, including HBV, HIV, HCV ELISA reagents